FGFR3 and Miyoshi myopathy: Specifically, two ligands of FGFR3, FGF2 and FGF8, have been shown to enhance FGFR3 downstream signaling in several MM cell lines, increasing phospholipase C gamma (PLCγ) phosphorylation (162).